Evidence map›Paper›PMID 32854747›Full record

ArticleParasites & vectors2020

Molecular evidence confirms occurrence of Rhipicephalus microplus Clade A in Kenya and sub-Saharan Africa.

Esther G Kanduma, David Emery, Naftaly W Githaka, Edward K Nguu, Richard P Bishop, Jan Šlapeta

Abstract read
In one paragraph

Article in Parasites & vectors, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Copy Number Variation-Based Molecular Sexing ofbioRxiv : the preprint server for biology · 2025
    Article
  3. Review
  4. Article
  5. Distribution ofParasite epidemiology and control · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Genetic Diversity ofPathogens (Basel, Switzerland) · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Low Genetic Diversity of the Only Clade of the TickPathogens (Basel, Switzerland) · 2023
    Article
  15. Article
  16. Article
  17. Molecular characterization ofJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Esther G KandumaDepartment of Biochemistry, School of Medicine, University of Nairobi, P.O. Box 30197-00100, Nairobi, Kenya. ekanduma@uonbi.ac.ke.ORCID http://orcid.org/0000-0002-4979-2681
David EmerySydney School of Veterinary Science (SSVS), University of Sydney, Sydney, NSWs, Australia.
Naftaly W GithakaInternational Livestock Research Institute (ILRI), P.O. Box 30709-00100, Nairobi, Kenya.
Edward K NguuDepartment of Biochemistry, School of Medicine, University of Nairobi, P.O. Box 30197-00100, Nairobi, Kenya.
Richard P BishopDepartment of Veterinary Microbiology and Pathology, Washington State University, Pullman, USA.
Jan ŠlapetaSydney School of Veterinary Science (SSVS), University of Sydney, Sydney, NSWs, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe tick vector Rhipicephalus microplus which transmits Babesia spp. and rickettsial pathogens has not been reported in Kenya since 1998. More recently, the pathogenic Babesia bovis has been detected in cattle blood DNA. The status of R. microplus in Kenya remains unknown. This study employed morphological and molecular tools to characterize R. microplus originating from Kenya and assess the genetic relationships between Kenyan and other African R. microplus genotypes.

methodsTicks were collected in south-eastern Kenya (Kwale County) from cattle and characterized to investigate the existence of R. microplus. Genetic and phylogenetic relationships between the Kenyan and other annotated R. microplus reference sequences was investigated by analysis of the cytochrome c oxidase subunit 1 (cox1) gene. To further characterize Kenyan ticks, we generated low coverage whole genome sequences of two R. microplus, one R. decoloratus and R. appendiculatus. A B. bovis specific TaqMan probe qPCR assay was used to detect B. bovis in gDNA from R. microplus ticks.

resultsOccurrence of R. microplus was confirmed in Kwale County, Kenya. The Kenyan R. microplus cox1 sequences showed very high pairwise identities (> 99%) and clustered very closely with reference African R. microplus sequences. We found a low genetic variation and lack of geographical sub-structuring among the African cox1 sequences of R. microplus. Four complete mitochondrial (mt) genomes for two R. microplus, one R. decoloratus and one R. appendiculatus were assembled from next generation sequence data. The mitochondrial genome sequences of the two Kenyan R. microplus ticks clustered closely with reference genome sequences from Brazil, USA, Cambodia and India forming R. microplus Clade A. No B. bovis was detected in the Kwale R. microplus DNA.

conclusionsThese findings confirm the presence of R. microplus in Kenya and suggest that R. microplus Clade A is prevalent in cattle in sub-Saharan Africa. These and other recent findings of widespread occurrence of R. microplus in Africa provide a strong justification for urgent surveillance to determine and monitor the spread of R. microplus and vector competence of Boophilus ticks for B. bovis in Africa, with the ultimate goal of strategic control.

Indexed as

RhipicephalusAnimalsArachnid VectorsBabesia bovisCattleCattle DiseasesDisease VectorsElectron Transport Complex IVEpidemiological MonitoringGenes, ProtozoanGenome, MitochondrialKenyaPathology, MolecularPhylogenyTick InfestationsElectron Transport Complex IVBabesia bovisBabesiosiscox1Genetic differentiationMitochondrial genomePhylogeneticsRhipicephalusRhipicephalus decoloratusTicks

Identifiers

PMID32854747
PMCPMC7453536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.